Viewing nowMontelukast Chewable Tablets 4 mg (Montelukast Sodium)
Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

MFDS item code 201500943 · Approved 2015.02.24 · Insurance code 645208640
Prevention and maintenance treatment of asthma; relief of allergic rhinitis symptoms
This medication helps to prevent asthma attacks and provides continuous treatment. It is also used to relieve symptoms caused by seasonal and perennial allergic rhinitis.
This medicine is taken once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the administration time should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 film once daily in the evening. Adults and adolescents aged 15 years and older: Administer montelukast 10 mg orally once daily. Adults and adolescents aged 15 years and older: Place montelukast 10 mg on the tongue once daily and take without water once it disintegrates. Adults and adolescents aged 15 years and older: Place montelukast 10 mg on the tongue once daily and allow it to dissolve; take without water. ○ How to take the dry syrup (for syrup only) Pour 1 sachet of this medicine into a cup, add 10 mL of water, stir well, and take. Do not open the package until immediately before use. After opening, suspend in water and take the entire amount immediately (within 15 minutes). Do not leave this medicine suspended in water for a long time. ○ How to take the granules (for granules only) The 4 mg granules may be taken directly by mouth or mixed with a small amount (approximately 5 mL) of soft food at room temperature or cooler, such as baby food, breast milk, or porridge. Do not open the package until immediately before use. After opening, immediately (within 15 minutes) mix with baby food, breast milk, or food, or take the entire amount as is. Do not leave this medicine mixed with baby food, breast milk, or food for a long time; discard any leftovers. This formulation is not intended to be mixed with beverages other than baby food or breast milk, but a beverage may be taken immediately after administration. This medicine may be taken regardless of meal times.
Children aged 6~14 years (5 mg chewable tablet): Chew montelukast 5 mg once daily. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years (4 mg chewable tablet): Chew montelukast 4 mg once daily. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 6~14 years (5 mg orally disintegrating tablet): Place montelukast 5 mg on the tongue once daily and take without water once it disintegrates. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years (4 mg orally disintegrating tablet): Place montelukast 4 mg on the tongue once daily and take without water once it disintegrates. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 6~14 years (5 mg orally dissolving film): Place montelukast 5 mg on the tongue once daily and allow it to dissolve; take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years (4 mg orally dissolving film): Place montelukast 4 mg on the tongue once daily and allow it to dissolve; take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 6~14 years (5 mg dry syrup): Administer montelukast 5mg orally once daily. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years (asthma, 4 mg granules): Administer montelukast 4 mg orally once daily. Infants aged 12 months~under 2 years (asthma, 4 mg granules): Administer this medicine 4 mg orally once daily in the evening. Efficacy and safety for asthma have not been established in infants under 12 months. Children aged 2~5 years (allergic rhinitis, 4 mg granules): Administer montelukast 4 mg orally once daily. Efficacy and safety for seasonal allergic rhinitis have not been established in infants under 2 years. Infants aged 6 months~under 2 years (perennial allergic rhinitis, 4 mg granules): Administer this medicine 4mg orally once daily. Efficacy and safety for perennial allergic rhinitis have not been established in infants under 6 months.
This medication contains the artificial sweetener aspartame, which is broken down in the body to phenylalanine. Therefore, patients with the hereditary disease phenylketonuria should not take this medication. Additionally, this medication contains lactose; patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not use this medication. While this medication helps alleviate asthma or allergic rhinitis symptoms, it is not a treatment used during acute asthma attacks. Therefore, individuals with acute symptoms should always have appropriate emergency medications on hand. During treatment, rare but serious vascular symptoms such as eosinophilia may occur; thus, a doctor should carefully monitor for skin rashes, worsening pulmonary symptoms, heart problems, or neuropathy. It is advisable to avoid taking this medication concurrently with aspirin or non-steroidal anti-inflammatory drugs, particularly for patients with hypersensitivity to aspirin. Safety has been confirmed in clinical trials for children, adolescents, and adults; however, safety and efficacy have not been established in infants under 6 months of age. Women who are pregnant or breastfeeding should consult with a physician before taking this medication, and it should only be used when clearly necessary. In case of overdose, there is no specific antidote, so general symptomatic treatment and clinical monitoring are necessary, and immediate medical attention should be sought if symptoms occur. This medication is sensitive to light, so it should be opened just before use, and it is best taken within 15 minutes after preparation. If neuropsychiatric symptoms such as anxiety, depression, hallucinations, or sleep disturbances occur during treatment, immediate consultation with a physician is required. Do not arbitrarily reduce or discontinue other asthma treatments while taking this medication, and always follow a doctor's instructions. Finally, keep this medication out of the reach of children and be careful not to transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to moisture and light, so it should be stored in a dry, dark place. A storage temperature between 1 and 30 degrees Celsius is recommended. Additionally, it must be kept in a tightly sealed container to maintain its efficacy.
Pink, oval-shaped, chewable tablet that is convex on both sides
28 tablets/PTP (7 tablets/PTP x 4)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMontelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.